Type of security: Stock
Sector: Health Care
Industry: Medical/Dental Instruments
The data is delayed by 15 minutes.
Description: NuVasive, Inc., a medical device company, develops and markets minimally disruptive surgical products and procedurally integrated solutions for the spine. Its products focus on applications for spine fusion surgery. The company?s principal product offering includes a minimally disruptive surgical platform, known Maximum Access Surgery (MAS) that includes its proprietary software-driven nerve detection and avoidance systems, NVM5 and NVJJB, and intra-operative monitoring (IOM) support; MaXcess, an integrated split-blade retractor system; and various specialized implants. Its spine surgery product line offerings comprise products for the thoracolumbar and the cervical spine, which are primarily used to enable access to the spine and to perform restorative and fusion procedures in a minimally disruptive fashion. The company?s biologic product line offerings used to aid the spinal fusion process or bone healing consist of allograft (donated human tissue); Osteocel Plus, an allograft cellular matrix containing via
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||EPS||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||6.84%||Sales Growth - Q/Q||5.47%||P/E|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||3.69%||ROE||7.11%||ROI||4.18%|
|Current Ratio||5.17||Quick Ratio||3.93||Long Term Debt/Equity||0.67||Debt Ratio||0.2|
|Gross Margin||76.15%||Operating Margin||15.49%||Net Profit Margin||6.01%||Dividend Payout Ratio|
|Cash From Financing Activities||-26.25 M||Cash From Investing Activities||-72.14 M||Cash From Operating Activities||35.18 M||Gross Profit||154.5 M|
|Net Profit||10.27 M||Operating Profit||25.86 M||Total Assets||1.29 B||Total Current Assets||684.33 M|
|Total Current Liabilities||132.44 M||Total Debt||368.5 M||Total Liabilities||618.32 M||Total Revenue||202.91 M|
|High 52 week||71.41||Low 52 week||44.53||Last close||44.53||Last change||0%|
|RSI||24.85||Average true range||2.17||Beta||1||Volume||185.56 K|
|Simple moving average 20 days||-11.38%||Simple moving average 50 days||-20.45%||Simple moving average 200 days||-23.47%|
|Performance Week||-8.13%||Performance Month||-20.65%||Performance Quart||-36.09%||Performance Half||-17.26%|
|Performance Year||-19.85%||Performance Year-to-date||-10.15%||Volatility daily||2.6%||Volatility weekly||5.81%|
|Volatility monthly||11.91%||Volatility yearly||41.26%||Relative Volume||231.69%||Average Volume||742.72 K|
|New High||New Low|
2019-01-15 08:06:15 | See what the IHS Markit Score report has to say about NuVasive Inc.
2019-01-11 12:24:19 | Tamarack Capital Management’s Return, AUM, and Holdings
2019-01-10 08:12:12 | Did NuVasive, Inc. NASDAQ:NUVA Insiders Buy Up More Shares?
2019-01-10 08:03:02 | Why Globus Medical Stock Rose 10% on January 9
2019-01-09 08:06:55 | See what the IHS Markit Score report has to say about NuVasive Inc.
2019-01-07 17:20:00 | Stocks making the biggest moves after hours: Union Pacific, Lennar and more
2019-01-03 09:07:02 | Solid Global Business Aids NuVasive Amid Pricing Pressure
2018-12-27 16:05:00 | NuVasive To Participate In 37th Annual J.P. Morgan Healthcare Conference
2018-12-21 08:06:15 | See what the IHS Markit Score report has to say about NuVasive Inc.
2018-12-20 08:06:44 | See what the IHS Markit Score report has to say about NuVasive Inc.
2018-12-19 18:24:59 | See what the IHS Markit Score report has to say about NuVasive Inc.
2018-12-14 03:32:17 | NuVasive, Inc. NUVA: Are Hedge Funds Right About This Stock?
2018-12-13 08:07:15 | See what the IHS Markit Score report has to say about NuVasive Inc.
2018-12-12 08:27:01 | NuVasive's Monolith Corpectomy System Ok'd for Expanded Use
2018-12-11 09:23:16 | Is There Now An Opportunity In NuVasive, Inc. NASDAQ:NUVA?
2018-12-11 08:07:15 | See what the IHS Markit Score report has to say about NuVasive Inc.
2018-12-11 07:45:00 | New Research Coverage Highlights Facebook, Korn/Ferry International, NuVasive, Sonic Automotive, B Communications, and Marin Software — Consolidated Revenues, Company Growth, and Expectations for 2018
2018-12-10 08:30:00 | NuVasive Grows Cervical Spinal Interbody Portfolio With PEEK Corpectomy Implant
2018-12-06 08:07:18 | See what the IHS Markit Score report has to say about NuVasive Inc.
2018-12-04 08:06:46 | See what the IHS Markit Score report has to say about NuVasive Inc.
2018-11-30 08:07:13 | See what the IHS Markit Score report has to say about NuVasive Inc.
2018-11-29 09:31:02 | NuVasive NUVA Up 11% Since Last Earnings Report: Can It Continue?
2018-11-28 08:07:14 | See what the IHS Markit Score report has to say about NuVasive Inc.
2018-11-27 08:07:18 | See what the IHS Markit Score report has to say about NuVasive Inc.
2018-11-24 08:07:17 | See what the IHS Markit Score report has to say about NuVasive Inc.
2018-11-19 16:05:00 | NuVasive To Participate In The 30th Annual Piper Jaffray Healthcare Conference
2018-11-15 09:09:02 | NuVasive Porous PEEK Implant OK'd for Use in XLIF Procedure
2018-11-15 08:06:46 | See what the IHS Markit Score report has to say about NuVasive Inc.
2018-11-08 16:05:00 | NuVasive's Proprietary Porous PEEK™ Implant To Be Used In Flagship XLIF® Procedure
2018-11-02 08:55:00 | New Research: Key Drivers of Growth for Edison International, NuVasive, LogMein, Anika Therapeutics, First Industrial Realty Trust, and ON Semiconductor — Factors of Influence, Major Initiatives and Sustained Production
2018-10-31 12:59:00 | Why NuVasive, Inc. Stock Is Sinking Today
2018-10-31 10:55:02 | NuVasive NUVA Q3 Earnings Lag Estimates, Revenues Top Mark
2018-10-31 08:03:00 | NuVasive Makes a Big Bet for 2019
2018-10-31 00:03:48 | Edited Transcript of NUVA earnings conference call or presentation 30-Oct-18 8:30pm GMT
2018-10-30 20:18:46 | NuVasive Inc NUVA Q3 2018 Earnings Conference Call Transcript
2018-10-30 17:55:09 | NuVasive NUVA Q3 Earnings Miss Estimates
2018-10-30 16:52:01 | NuVasive: 3Q Earnings Snapshot
2018-10-30 16:02:00 | NuVasive Reports Third Quarter 2018 Financial Results
2018-10-29 13:18:52 | 1 Extraordinary Investor, Plus a 5-Stock Sampler Annual Check-In
2018-10-19 13:02:00 | NuVasive's stock tumble on CEO departure presents buying opportunity, analyst says
2018-10-19 08:42:00 | NuVasive CEO Lucier to step down, names Chris Barry as successor
2018-10-16 08:07:14 | See what the IHS Markit Score report has to say about NuVasive Inc.
2018-10-11 16:05:00 | NuVasive Announces Conference Call And Webcast Of Third Quarter 2018 Results